Prosecution Insights
Prosecution Insights
15 pending office actions • 7 art units • 12 examiners • 0 of 15 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (13%) |
| §112 only | 3 (20%) |
| Double-patenting + other | 2 (13%) |
| No statute on record | 8 (53%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NATARAJAN, MEERA | 2 | 62.2% | +16.8% |
| YOUTCHOM PENDIE, EMMANUEL LED | 2 | 60.0% | +50.0% |
| CANELLA, KAREN A | 2 | 62.6% | +32.9% |
| NICKOL, GARY B | 1 | 43.9% | +26.4% |
| MOSELEY II, NELSON B | 1 | 68.1% | +41.7% |
| STOICA, ELLY GERALD | 1 | 66.5% | +22.9% |
| MELCHIOR, JAMES RYLAND | 1 | 61.0% | +44.6% |
| MERTZ, PREMA MARIA | 1 | 71.5% | +36.1% |
| JUEDES, AMY E | 1 | 44.5% | +41.0% |
| WU, JULIE ZHEN QIN | 1 | 61.8% | +52.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18185649 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | WU, JULIE ZHEN QIN | 149d overdue |
| 18192743 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | JUEDES, AMY E | 120d overdue |
| 18297076 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | MERTZ, PREMA MARIA | 112d overdue |
| 18297064 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | STOICA, ELLY GERALD | 79d overdue |
| 18297069 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | MELCHIOR, JAMES RYLAND | 60d overdue |
| 18154091 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS | CANELLA, KAREN A | 50d overdue |
| 18154098 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS | CANELLA, KAREN A | 49d overdue |
| 18315183 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | MOSELEY II, NELSON B | 27d |
| Art Unit | Apps |
|---|---|
| 1643 | 6 |
| 1647 | 3 |
| 1644 | 2 |
| 1642 | 1 |
| 1674 | 1 |
| 1675 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18511308 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | NATARAJAN, MEERA | 1643 | §112 | Non-Final OA | 76d | Pending | Nov 16, 2023 |
| 18451216 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | NICKOL, GARY B | 1643 | DPOther | Non-Final OA | 69d | Pending | Aug 17, 2023 |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | Other | Non-Final OA | 34d | Pending | May 25, 2023 |
| 18314878 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §103 | Non-Final OA | 63d | Pending | May 10, 2023 |
| 18315183 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | MOSELEY II, NELSON B | 1642 | Other | Non-Final OA | 27d | Pending | May 10, 2023 |
| 18301545 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | NATARAJAN, MEERA | 1643 | DPOther | Final Rejection | 70d | Pending | Apr 17, 2023 |
| 18297064 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | STOICA, ELLY GERALD | 1647 | §112 | Non-Final OA | 79d overdue | Pending | Apr 07, 2023 |
| 18297069 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | MELCHIOR, JAMES RYLAND | 1644 | Other | Non-Final OA | 60d overdue | Pending | Apr 07, 2023 |
| 18297076 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | MERTZ, PREMA MARIA | 1674 | Other | Non-Final OA | 112d overdue | Pending | Apr 07, 2023 |
| 18192743 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | JUEDES, AMY E | 1644 | Other | Non-Final OA | 120d overdue | Pending | Mar 30, 2023 |
| 18185649 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | WU, JULIE ZHEN QIN | 1643 | Other | Non-Final OA | 149d overdue | Pending | Mar 17, 2023 |
| 18178055 | PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS | FONTAINHAS, AURORA M | 1675 | Other | Non-Final OA | 153d overdue | Pending | Mar 03, 2023 |
| 18158734 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | HAM, JIEUN | 1600 | §103 | Non-Final OA | — | Pending | Jan 24, 2023 |
| 18154091 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS | CANELLA, KAREN A | 1643 | §112 | Non-Final OA | 50d overdue | Pending | Jan 13, 2023 |
| 18154098 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS | CANELLA, KAREN A | 1643 | Other | Non-Final OA | 49d overdue | Pending | Jan 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial